Advanced Technology Acquisition Corp. 

(Public, AMEX:AXC)   Watch this stock   
Find more results for AXC

Key stats and ratios

Q1 (Mar '09) 2008
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets 0.45% 1.78%
Return on average equity 0.45% 1.78%

Address

14 A Achimeir Street
Ramat Gan, 52587
Israel
+972-3-7513707 (Phone)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Advanced Technology Acquisition Corp. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Advanced Technology Acquisition Corp. discussions

  View all discussions »

Description

Advanced Technology Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination with a technology or technology-related business that has operations or facilities located in Israel, or that intends to establish operations or facilities in Israel, such as research and development, manufacturing or executive offices, following its initial business combination. On December 19, 2008, the Company entered into a letter of intent with Bioness Inc., a Delaware corporation (Bioness), which provides for a business combination between Bioness (or an entity controlled by Bioness) and the Company by means of a merger.

Officers and directors

Moshe Bar-Niv
Chairman of the Board
Age: 60
Bio & Compensation - Reuters
Liora Lev
Chief Executive Officer, Director
Age: 55
Bio & Compensation - Reuters
Ido Bahbut
Chief Financial Officer, Treasurer, Secretary
Age: 34
Bio & Compensation - Reuters
Yehoshua Jacob Gleitman
Chief Technology Officer, Director
Age: 59
Bio & Compensation - Reuters
Elisha Yanay
Director
Age: 64
Bio & Compensation - Reuters
Yoram Buki
Director
Age: 55
Bio & Compensation - Reuters
Nathan Sharony
Director
Age: 74
Bio & Compensation - Reuters
Yacov Rozen
Director
Age: 56
Bio & Compensation - Reuters